Suchergebnisse - "Andrea Vettori"

1

Glucocorticoids promote Von Hippel Lindau degradation and Hif-1α stabilization

von: Andrea Vettori

2017, in: Proceedings of the National Academy of Sciences of the United States of America

Wird geladen...
2

Modeling Human Muscular Dystrophies in Zebrafish: Mutant Lines, Transgenic Fluorescent Biosensors, and Phenotyping Assays

von: Chiara Tesoriero

2023, in: International Journal of Molecular Sciences

Wird geladen...
3

A GFP-Tagged Gross Deletion on Chromosome 1 Causes Malignant Peripheral Nerve Sheath Tumors and Carcinomas in Zebrafish.

von: Matteo Astone

2015, in: PLoS ONE

Wird geladen...
4

Autosomal Dominant Tubulointerstitial Kidney Disease with Adult Onset due to a Novel Renin Mutation Mapping in the Mature Protein

von: Céline Schaeffer

2019, in: Scientific Reports

Wird geladen...
5

Antitumor Effect of Berberine Analogs in a Canine Mammary Tumor Cell Line and in Zebrafish Reporters via Wnt/β-Catenin and Hippo Pathways

von: Alessandro Sammarco

2023, in: Biomedicines

Wird geladen...
6

Ubiquitylation of the ER-Shaping Protein Lunapark via the CRL3KLHL12 Ubiquitin Ligase Complex

von: Laurensia Yuniati

2020, in: Cell Reports

Wird geladen...
7

Hyperactivation of Wnt/β-catenin and Jak/Stat3 pathways in human and zebrafish foetal growth restriction models: Implications for pharmacological rescue

von: Giovanni Risato

2022, in: Frontiers in Cell and Developmental Biology

Wird geladen...
8

Progressively De-Differentiated Pancreatic Cancer Cells Shift from Glycolysis to Oxidative Metabolism and Gain a Quiescent Stem State

von: Giulia Ambrosini

2020, in: Cells

Wird geladen...
9

A novel DSP zebrafish model reveals training- and drug-induced modulation of arrhythmogenic cardiomyopathy phenotypes

von: Rudy Celeghin

2023, in: Cell Death Discovery

Wird geladen...
10

Efficient clofilium tosylate-mediated rescue of POLG-related disease phenotypes in zebrafish

von: Nicola Facchinello

2021, in: Cell Death and Disease

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!